Home › Funds › Siren, L.L.C. › EWTX

Siren, L.L.C. position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Siren, L.L.C. reported holding 2,804,179 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$113.8M, representing 2.70% of its reported portfolio and ranking #9 among its reported holdings. Siren, L.L.C. has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)2.80M sh
Reported value held$113.85M
Portfolio Weight2.70%
First reportedQ3 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s EWTX position evolved

Siren, L.L.C. first disclosed a stake in EWTX in Q3 2024 at 404,113 shares (US$10.8M). The position peaked in Q1 2026 at 4,430,263 shares, worth US$139.6M. Across 9 filings, Siren, L.L.C. increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,804,179 shares valued at US$113.8M — a reduction of -380,450 shares quarter over quarter.. Notable position changes include a 82% increase in Q4 2024 (shares fell 18% over the following quarter), a 131% increase in Q1 2025 (shares fell 40% over the following quarter), a 86% increase in Q2 2025 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 404.11K $10.79M New
Q4 2024 734.34K $19.61M Add
Q1 2025 1.70M $37.32M Add
Q2 2025 3.16M $41.43M Add
Q3 2025 3.90M $63.21M Add
Q4 2025 4.53M $112.41M Add
Q1 2026 4.43M $139.55M Reduce
Q2 2026 3.18M $129.39M Reduce
Q3 2026 2.80M $113.85M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Siren, L.L.C. held EWTX?

Siren, L.L.C. has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in EWTX?

As of Q3 2026, Siren, L.L.C. holds 2.80M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $113.85M, representing 2.70% of its reported portfolio and ranking #9.

Has Siren, L.L.C. been buying or selling EWTX?

In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in EWTX. The position peaked in Q1 2026 at 4.43M shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.